Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: Daly M, Robinson E. Willingness to vaccinate against COVID-19 in the US: Longitudinal evidence from a nationally representative sample of adults from April- October 2020. medRxiv [Preprint]. 2020 Nov 30:2020.11.27.20239970. doi: 10.1101/2020.11.27.20239970.
Implications for practice and research
Studies targeting the reasons that discourage vaccination are relevant.
The knowledge of these reasons gives support to the improvement of public policies of education and incentive to immunisation of the population.
In February 2020, the WHO named COVID-19 the newly emerging viral infection caused by a new coronavirus nominated SARS-CoV-2. This infection resulted in a pandemic.1
Currently, vaccines that prevent severe infection by SARS-CoV-2, developed in unprecedented time frames, are identified as the most promising approach to contain the pandemic and are being widely adopted.
On the other hand, there is a concern about receiving the immunising agent and questions regarding its safety, since there are no in-depth studies on its effectiveness and efficiency, as well as on its long-term adverse effects.2 …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.